Drug
Becaplermin clinical trials
Also written Regranex®.
- studies test it
- 10
- open now
- 1
- in phase 3
- 2
- first study started
- 2000
Keep track of what changes. Save the Becaplermin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2024 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 5
- Phase 3
- 2
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 6
Vanderbilt University Medical Center (1) · Alexander Hawkins (1) · BioMimetic Therapeutics (1) · University of Pennsylvania (1) · Assistance Publique - Hôpitaux de Paris (1) · Universidad Autonoma de Nuevo Leon (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · Lynch Biologics LLC (1)
Often tested with
Tested in the same studies.
Proto-Oncogene Proteins c-sis (1) · Platelet-Derived Growth Factor Subunit B (1) · AD 5 (1) · Allografting (1)
Studies
Open first, then newest update. How each study uses Becaplermin is read from its arms, and is right about nine times in ten.
Testing it · 10
- Periodontal Regeneration With Recombinant Human Platelet Derived Growth Factor (rH-PDGF-BB) and AllograftRecruitingPhase 2Universidad Autonoma de Nuevo LeonNCT06162832Written as Allograft and rHPDGF-BB
- Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck ReconstructionCompletedPhase 2Vanderbilt University Medical CenterNCT06634030Written as RhPDGF-BB
- Evaluating an rhPDGF-BB-enhanced Collagen Plug for Perianal Fistula HealingCompletedPhase 2Alexander HawkinsNCT06632418Written as RhPDGF-BB
- Phase II Study of the Effects of rhPDGF-BB Injection on Lateral EpicondylitisCompletedPhase 2BioMimetic TherapeuticsNCT01746420Written as rhPDGF-BB Injection
- Evaluation of ABSOLVE in Diabetic Foot UlcersStatus unknownPhase 2Lynch Biologics LLCNCT03037970Written as RhPDGF-BB
- Preliminary Testing of New Treatment for Chronic Leg WoundsCompletedPhase 1University of PennsylvaniaNCT00000431Written as PDGF-B/Ad5
- Becaplermin Gel for MARTORELL's Hypertensive Leg UlcersCompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT00970697Written as becaplermin gel
- A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEXTerminatedPhase 3Johnson & Johnson Pharmaceutical Research & Development, L.L.C.NCT00034788Written as Becaplermin
- Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic UlcersStatus unknownNot applicableSouthern California Institute for Research and EducationNCT00446472Written as Regranex®
- TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot UlcersStatus unknownNot applicableSolsys Medical LLCNCT00389636Written as Regranex
Given in every arm · 1 — Becaplermin is usual care beside what is tested
As the comparator · 1 — what is tested is compared with Becaplermin
Codes
What other systems call Becaplermin · ClinicalTrials.gg INT006669
- MeSH (NLM) D000077214BecaplerminConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1B56C968OABECAPLERMINConfirmed FDA, NLM, Wikidata
- RxNorm 115238Confirmed FDA, Wikidata
- Wikidata Q2313188becaplerminConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1668BecaplerminOne source FDA
- DrugBank DB00102One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077214 | Becaplermin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1B56C968OA | BECAPLERMIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 115238 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2313188 | becaplermin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1668 | Becaplermin | One source FDA |
| DrugBank | DB00102 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.